3-(Methylthio)propionaldehyde
Common Name: |
3-(Methylthio)propionaldehyde |
IUPAC Name: |
3-methylsulfanylpropanal |
Molecular Formula: |
C4H8OS |
SMILES: |
CSCCC=O |
Inchi: |
1S/C4H8OS/c1-6-4-2-3-5/h3H,2,4H2,1H3 |
Inchi Key: |
CLUWOWRTHNNBBU-UHFFFAOYSA-N |
Cas No: |
3268-49-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
104.17 |
Mass (g/mol) |
104.03 |
Molar Refractivity |
29.13 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
3 |
Rings |
|
TPSA |
42.37 |
Hetero Atoms |
2 |
Heavy Atoms |
6 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
-75 |
Boiling Point (°C@760.00mm Hg) |
165.00 to 166.00 |
Vapor Pressure (mmHg@25.00 °C) |
1.641 |
Vapor Density (Air =1) |
3.5 |
Fraction Csp3 |
0.75 |
LogP |
0.938 |
iLOGP |
1.10 |
XLOGP3 |
0.31 |
WLOGP |
0.94 |
MLOGP |
0.60 |
ESOL Log S |
-0.48 |
ESOL Solubility (mg/ml) |
34.2 |
ESOL Solubility (mol/l) |
0.329 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-0.76 |
Ali Solubility (mg/ml) |
18 |
Ali Solubility (mol/l) |
0.17 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.06 |
Silicos-IT Solubility (mg/ml) |
8.99 |
Silicos-IT Solubility (mol/l) |
0.09 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.72 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.844 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.53 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |